Talk:Virosome

Viruses Low‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles
Low	This article has been rated as Low-importance on the project's importance scale.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Wiki Education Foundation-supported course assignment

Latest comment: 2 years ago1 comment1 person in discussion

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Rachaelmendoza.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 12:28, 17 January 2022 (UTC)Reply

Assessment comment

Latest comment: 17 years ago1 comment1 person in discussion

The comment(s) below were originally left at Talk:Virosome/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Virosomes therefore represent an innovative, broadly applicable adjuvant and carrier system with prospective applications in areas beyond conventional vaccines. They are one of only three adjuvant systems widely approved by regulatory authorities and the only one that has carrier capabilities. This reads like an advertisement -- not really surprising given that it is directly quoted from the site of a company that sells IP relating to virosomes =651On. A greater diversity of sources is needed here. --DavidHopwood 00:18, 28 July 2007 (UTC)Reply

Last edited at 00:18, 28 July 2007 (UTC). Substituted at 10:02, 30 April 2016 (UTC)

Add topic